*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Ticagrelor is a potent, reversible <strong>P2Y12 receptor antagonist</strong> used in antiplatelet therapy. Synthesized via multi-step organic processes, its molecular formula is <strong>C23H28F3N5O4S</strong> (CAS No. 466707-06-2).</p>
<h3>Application</h3>
<ul>
<li><strong>Cardiovascular Pharmaceuticals:</strong> Prevention of thrombotic events in acute coronary syndrome.</li>
<li><strong>Drug Manufacturing:</strong> API production for combination therapies with aspirin.</li>
<li><strong>Clinical Research:</strong> Usage in trials evaluating novel antithrombotic regimens.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in patients with active bleeding or history of intracranial hemorrhage. Store under controlled room temperature (<strong>20-25°C</strong>) in moisture-proof containers to maintain stability.</p>